Barr Still On The Hook In Ovcon Antitrust Suit
A federal judge has refused to throw out three antitrust class actions accusing Barr Pharmaceuticals Inc. of accepting a $20 million payment in exchange for keeping a generic version of oral...To view the full article, register now.
Already a subscriber? Click here to view full article